CLINICAL_TRIALS
trial_result
· 2018-07-05
Clinical Trial Update: Vilazodone for Corticosteroid-Induced Memory Impairment [Phase 2]
Summary
Phase 2 trial update evaluating vilazodone for memory impairment due to corticosteroid use completed with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Texas Southwestern Medical Center | Conditions: Memory Impairment | Phase 2 | Status: COMPLETED | Results posted: 2018-07-05